Sancuso FDA Approval History
FDA Approved: Yes (First approved September 12, 2008)
Brand name: Sancuso
Generic name: granisetron
Dosage form: Transdermal Patch
Company: ProStrakan Group plc
Treatment for: Nausea/Vomiting, Chemotherapy Induced
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.
Development timeline for Sancuso
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
